APOE and coronary artery disorder: In our analysis, we had over 10,000 CHD cases in over 130,000 individuals, meaning that the absence of evidence for heterogeneity in the estimates of APOE genotype with odds of CHD when stratified by smoking status indicates that a clinically relevant difference between smoking subgroups is very unlikely.